Diovan Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

" Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD "
Conditions:   Congenital Heart Disease;   Heart Failure;   Heart Failure With Reduced Ejection Fraction Interventions:   Drug: Sacubitril 49 MG / Valsartan 51 MG [Entresto] BID;   Drug: Empagliflozin 10 MG OD;   Drug: Sacubitril 49 MG / Valsartan 51 MG [Entresto] BID and Empagliflozin 10 MG OD Sponsors:   Instituto Nacional de Cardiologia Ignacio Chavez;   Boehringer Ingelheim laboratory Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 14, 2022 Category: Research Source Type: clinical trials